Adjuvant therapy for colo-rectal cancer.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D011897:Random Allocation; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D012008:Recurrence; D012673:Semustine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; C011499:methanol extraction residue (MER) tubercle bacillus fraction; D012673:Semustine; D005472:Fluorouracil